Showing results (121-130 of 211) with videos related to

Sort By:
Pageof 22
Epilepsy & Behavior Reports|March 4, 2026
CORE-VNS: Dosing and titration of VNS therapy in contemporary clinical practiceRyan Verner, Francesca Beraldi, Michal Tzadok, et al.
The Lancet. Digital Health|March 24, 2023
Development and validation of a diagnostic aid for convulsive epilepsy in sub-Saharan Africa: a retrospective case-control studyGabriel Davis Jones, Symon M Kariuki, Anthony K Ngugi, et al.
Bjpsych Open|October 28, 2024
Evidencing the challenges of care delivery for people with intellectual disability and epilepsy in England by using the Step Together toolkitTom Shillito, Lance Watkins, Hafsha Ali, et al.
Epilepsy & Behavior : E&B|May 18, 2025
"The traditional healer said, 'I had a genie that scared me in my eyes, and that is why I fall": An ethnographic study in Mahenge, TanzaniaPendo F Magili, Isolide S Massawe, Vivian P Mushi, et al.
Pediatrics|February 5, 2008
Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardationAgatino Battaglia, H Eugene Hoyme, Bruno Dallapiccola, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2005
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoinSarah K Tate, Chantal Depondt, Sanjay M Sisodiya, et al.
Annals of Clinical and Translational Neurology|July 16, 2024
Distinct plasma metabolomic signatures differentiate autoimmune encephalitis from drug-resistant epilepsyWenzheng Xiong, Tianrong Yeo, Jeanne Tan May May, et al.
Epilepsy & Behavior : E&B|August 29, 2025
Levetiracetam in epilepsy and autism spectrum disorder: analysis of safety, tolerability, and efficacyJon Allard, William Henley, Brendan McLean, et al.
Epilepsia Open|August 3, 2026
Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension studyRima Nabbout, Orrin Devinsky, Lieven Lagae, et al.
Plos One|January 17, 2025
Translation, adaptation and validation of an epilepsy screening instrument in two Ghanaian languagesEmmanuel Kwame Darkwa, Sabina Asiamah, Elizabeth Awini, et al.
Pageof 22